drugset / Trial / NCT05076461

Ondansetron Versus Domperidone for Treating Vomiting in Acute Gastroenteritis in Children

NCT05076461

Completed 300 enrolled Tehsil Headquarter Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Most of the trials conducted comparing ondansetron and domperidone have been conducted among children aged below 5 or 6 years of age while no study from Pakistan has compared efficacy of these antiemetic agents among children up to 12 years of age. The findings of present study will give valuable evidence about the effectiveness of these antiemetic agents to prevent vomiting among children suffering with acute gastroenteritis at a resource limited setting of South Punjab, Pakistan.

Timeline

Start
2020-07-01
Primary completion
2021-06-30
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 0.15 mg/kg Oral

Indications